0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover438.13%IV49.32%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1213Delta0.0050Gamma7.67Leverage Ratio-0.1577Theta-0.0054Rho-0.93Eff Leverage0.0185Vega
Federated Hermes Stock Discussion
• $Cadence Design Systems(CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $Federated Hermes(FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $Goldman Sachs(GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $McDonald's(MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $Oracle(ORCL.US)$ : Exane Upg...
• $Actinium(ATNM.US)$ +30.81% (Actinum Pharma and Immedica to commercialize lomab-B (1311 apamistamab) in Europe the Middle East and North Africa)
• $Aeglea BioTherapeutics(AGLE.US)$ +18.11% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
• $Grid Dynamics(GDYN.US)$ +5% (expands in Europe ceases operations in Russia)
• $Artisan Partners Asset Management(APAM.US)$ +4....
No comment yet